|
- 2019
Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar AtaxiasDOI: 10.1007/s13311-018-00696-y Keywords: Spinocerebellar ataxia, SCA, polyglutamine disorders, gene therapy, stem cell-based therapy, antisense oligonucleotides Abstract: Worldwide prevalence of polyglutamine spinocerebellar ataxias. In the ADCA families investigated, no SCA17 was identified. The Netherlands [8]; Germany [9]; Japan [10]; the USA [11]; Portugal/Brazil [12]; Italy [13]; China [14]; South Africa [15]; India [16]. Figure based on Schols et al. [17] and adapted from Bird [18] (GeneReviews
|